InvestoGain

Investogain Pty Limited
AFS Licence No. 334036

All correspondence to:
admin@delisted.com.au
or by mail to:
PO Box 400
Crows Nest NSW 1585

26 April 2025

Name:	GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED (GEN)
Date of Listing:	22 September 2000
Date of Delisting:	30 August 2013

Stock Exchange Status: (updated daily)

This entity was delisted from the Australian Securities Exchange on 30 August 2013.

Legal Status: (updated monthly)

Deregistration Date: 19 May 2015

This entity was deregistered on 19 May 2015. It has thus ceased to exist.

Capital Gains Tax (CGT) Status: (updated at least quarterly)

This entity was deregistered on 19 May 2015. Deregistration is a Capital Gains Tax Event. In our opinion you are entitled to crystallise any capital loss in the tax year that deregistration occurs providing you have not previously done so. If you did not crystallise your loss in the tax year the entity was deregistered, you may seek to re-open that year’s assessment but anyway should seek professional advice as to how best to proceed.

Updates, corrections, disagreements please email to admin@delisted.com.au

Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.

Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.

Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.

GENESIS RESEARCH AND DEVELOPMENT CORPORATION LIMITED(GEN)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of GEN:

(4 out of 5)

COMPANY WEBSITE:

GEN website

GEN email

GEN investorRelations

GEN annualreports

REGISTRY:

6 Hope St Ermington NSW 2115

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 2 8235 8150
RegistryWebsite RegistryEmail

Company details

Address: Level 15 PWC Tower, 188 Quay St Auckland, New Zealand
Tel: +64 9 373 5600 Fax: +64 9 373 5601

Date first listed: 22/09/2000
Company Secretary:
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Biotechnology company with core technical expertise in the fields of genomics and immunology - company seeks novel biologics which can be used as therapeutics or as targets for new drug therapies - primary disease targets are inflammatory or atopic disord

News & Events

Expand this box to read and print

company deregistered today	19/05/2015
delisted following non-payment of annual listing fees in respect of the year ending 30 June 2014	30/08/2013
we understand this company failed and has finally been delisted by ASX following non-payment of annual listing fees	30/08/2013
The company has not paid its annual fees in respect of the year ending 30 June 2014 but are already suspended from official quotation. In accordance with listing rule 16.5, entities that pay their annual listing fees on or after 23 August 2013must pay by bank cheque only. Under listing rule 17.15, any entity that has not paid its annual listing fees as required by listing rule 16.5 by 5.00 pm EST on Thursday 29 August 2013 will be removed from the official list with effect from the close of trading on Thursday 29 August 2013.	23/08/2013
releases Preliminary Final Report	01/03/2013
The securities of Genesis Research and Development Corporation Limited (the "Company") will be suspended from quotation immediately, under listing rule 17.3, following the Company" announcement today that it ""¦has insufficient funds to continue, even as a as a non-operating investment entity". Security Code: GEN	13/11/2012
the suspension of trading in the securities of Genesis Research and Development Corporation Limited (the "Company") will be lifted before the commencement of trading on Monday, 5 September 2011 in accordance with listing rule 17.8, following lodgement of the Company's Half Year Accounts for the period ended 30 June 2011	02/09/2011
suspended from quotation following failure to lodge financial reports	01/09/2011

ASX Announcements (courtesy of ASX)

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

Company Updates

Post your comments here

Please read our Terms before posting comments.

Click here for free access to this company's:
ASX, Legal & CGT Status

Directors' on-market share transactions (last 5)

Click here for the last 20 transactions all companies

Directors & Executives (current)

NAME	TITLE	DATE OF APPT
Joachim von Roy	Chairman, Independent Director
Stephen Hall	CEO, Company Secretary	17/12/2004
Ewe Lim	CFO
Andy Gearing	Independent Director	26/01/2006
Steven Gillis	Independent Director
Daniel Mahnert-Lueg	Independent Director
Phi San Lam	Director	09/08/2013
Frankie Chen	Director	09/08/2013
Sharon Kwan	Director	09/08/2013
Gude Buer	Director	19/12/2012

Date of first appointment, title may have changed.

Directors & Executives (former)

NAME	TITLE	DATE OF APPOINTMENT	DATE OF RESIGNATION

Date of first appointment, title may have changed.